DIMENSIONAL FUND ADVISORS LP - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 1 filers reported holding XENON PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DIMENSIONAL FUND ADVISORS LP ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$14,593,012
+44.6%
427,125
+63.0%
0.01%
+66.7%
Q2 2023$10,090,975
+332.0%
262,107
+301.6%
0.00%
+200.0%
Q1 2023$2,335,870
+18725.5%
65,266
-79.3%
0.00%
-75.0%
Q4 2022$12,408
-99.9%
314,673
-8.0%
0.00%
-20.0%
Q3 2022$12,348,000
+132.0%
342,031
+95.5%
0.01%
+150.0%
Q2 2022$5,322,000
-40.7%
174,962
-40.4%
0.00%
-33.3%
Q1 2022$8,979,000
-1.5%
293,729
+0.6%
0.00%0.0%
Q4 2021$9,120,000
+294.8%
291,946
+93.1%
0.00%
+200.0%
Q3 2021$2,310,000
+728.0%
151,197
+907.3%
0.00%
Q2 2021$279,000
+153.6%
15,010
+35.0%
0.00%
Q2 2019$110,000
-2.7%
11,1200.0%0.00%
Q1 2019$113,000
+61.4%
11,1200.0%0.00%
Q4 2018$70,000
-52.4%
11,1200.0%0.00%
Q3 2018$147,000
+44.1%
11,1200.0%0.00%
Q2 2018$102,000
+88.9%
11,1200.0%0.00%
Q1 2018$54,000
+74.2%
11,1200.0%0.00%
Q4 2017$31,00011,1200.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 266,961$10,277,99912.45%
COMMODORE CAPITAL LP 1,845,000$71,032,5007.98%
Altium Capital Management LP 228,000$8,778,0006.64%
TLS Advisors LLC 33,756$1,3005.58%
GREAT POINT PARTNERS LLC 530,000$20,405,0003.99%
DAFNA Capital Management LLC 280,538$10,800,7132.95%
Paradigm Biocapital Advisors LP 989,327$38,089,0902.94%
Nan Fung Group Holdings Ltd 114,380$4,403,6302.81%
Avoro Capital Advisors LLC 4,900,000$188,650,0002.56%
Ghost Tree Capital, LLC 185,000$7,122,5002.35%
View complete list of XENON PHARMACEUTICALS INC shareholders